Procreate is an iPad-exclusive drawing app with a low one-time purchase price, and it offers a good selection of features. With 4.4 stars on the App Store from almost 50,000 ratings, it's one of the ...
Git isn't hard to learn, and when you combine Git and GitHub, you've just made the learning process significantly easier. This two-hour Git and GitHub video tutorial shows you how to get started with ...
Australia's supply of physical maps is at risk of disappearing as one of the country's last map stores prepares to close its doors in Adelaide. Cartographer Anthony Stephens owns The Map Shop on ...
COME A LONG WAY. I HAVE ALL THESE HIGHWAY MAPS THAT I PICK UP AT THE REST AREAS, MAPS. ANDY WOODRUFF PROUDLY SHOWS US THE HUNDREDS HE HAS COLLECTED OVER THE YEARS. THESE ARE MADE BY MAJOR CARTOGRAPHY ...
Although women have always been part of the mapping landscape, their contributions to cartography have long been overlooked. Mapmaking has traditionally featured men, from Mercator’s projection of the ...
– Collaboration leverages Cartography’s cutting-edge ATLAS and SUMMIT platforms to identify tumor-selective antigens; Pfizer to lead therapeutic development – – Cartography to receive upfront, ...
Cartography will use its platforms, Atlas and Summit, to discover tumor-selective antigens. (iStock/Getty Images Plus) Pfizer is penning a cancer discovery pact with Cartography Biosciences that could ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cartography Biosciences, Inc., a biotechnology company advancing a differentiated pipeline of antibody-based cancer therapies, today announced that the ...
Is it possible to create the “perfect” expression of data on a map? William Rankin doesn’t think so. While most mainstream maps that use a jigsaw-puzzle-like format — solid color shapes separated by ...
Not all maps chart the Earth’s surface — and the David Rumsey Map Center’s newest exhibition in Green Library proves just that. The exhibit “Above & Below: Cartography Beyond Terrain” opened on Oct. 8 ...
Colorectal cancer patients whose disease exhibits certain rare genetic signatures have the option of treatment with immunotherapies. But these targeted cancer treatments haven’t worked for patients ...
Cartography Biosciences, a San Francisco Bay Area biotechnology company, announced Thursday it raised a $67 million Series B round to propel its first drug prospect into clinical testing. Its lead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results